Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea

Fertil Steril. 1999 Dec;72(6):1118-20. doi: 10.1016/s0015-0282(99)00426-4.

Abstract

Objective: To assess the effect of supplementing an ovulation induction regimen of highly purified FSH with LH activity in the form of low-dose hCG therapy.

Design: Case report.

Setting: The Reproductive Endocrinology Center at the University of Bologna, Bologna, Italy.

Patient(s): A woman with weight-related secondary hypogonadotropic amenorrhea.

Intervention(s): The patient was treated first with highly purified FSH alone and then received highly purified FSH in combination with low-dose hCG therapy (50 IU/d).

Main outcome measure(s): Pelvic ultrasound examinations, serum E2 levels, duration of treatment, total dose of highly purified FSH, and outcome of treatment.

Result(s): The concomitant administration of low-dose hCG and highly purified FSH markedly reduced the duration of treatment and the dose of highly purified FSH, and resulted in a quadruplet pregnancy in a patient in whom several previous ovulation induction procedures had been unsuccessful.

Conclusion(s): Supplementation of an ovulation induction regimen with an agent that has LH activity can enhance FSH-induced folliculogenesis and markedly reduce costs in women with hypogonadotropic hypogonadism. However, this increased response can be associated with complications such as multiple gestation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amenorrhea / drug therapy*
  • Chorionic Gonadotropin / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Follicle Stimulating Hormone / therapeutic use*
  • Humans
  • Ovulation Induction / methods*
  • Pregnancy

Substances

  • Chorionic Gonadotropin
  • Follicle Stimulating Hormone